PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce that the Company has appointed  Dr. Cezar Khursigara to its Advisory Board. The Advisory Board will oversee all areas related to PUF Ventures’ medical cannabis research and development initiatives.

“We are honoured to have Dr. Khursigara join PUF’s Advisory Board,” said Derek Ivany, President and CEO of the Company. “Dr. Khursigara is a widely respected and accomplished researcher in the areas of microbiology and biotechnology.  He brings a cross disciplinary approach to our team and will play an integral role as we develop our own cannabis strains and proprietary genetics. This is an important appointment for our Company as we pursue production licenses in Canada and with our partner Solaris Nutraceuticals in Australia.”


Dr. Khursigara is a leading researcher focused on microbiology and biotechnology applications. He is an Associate Professor in the Department of Molecular and Cellular Biology and Director of the Molecular Imaging and Mass Spectrometry Facilities at the University of Guelph. In 1999, Dr. Khursigara received a Bachelor’s Degree from Ryerson University in Chemistry and Biology, and in 2005 he received a Doctorate in Microbiology and Immunology from McGill University. Dr. Khursigara has trained at the National Institutes of Health in Bethesda Maryland where he conducted post-doctoral research at the National Cancer Institute. Dr. Khursigara is funded by the Natural Science and Engineering Research Council of Canada, the Canadian Institutes of Health Research and the Ontario Ministry of Agriculture, Food and Rural Affairs.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany
President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

Click here to connect with PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF) and receive an Investors Presentation. 

Source: www.newswire.ca

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less

For the purposes of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, World High Life announces that the Company has 230,119,819 ordinary shares of 1p each in issue (“Ordinary Shares”), each share carrying the right to one vote. The figure of 230,119,819 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules

The Directors of the Company accept responsibility for the contents of this announcement.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces that it has granted an aggregate of 400,000 options at an exercise price of CDN$1.00, exercisable for a period of five years, to directors and officers of the Company. The stock options are being granted pursuant to the terms of the Company’s stock option plan, and are subject to regulatory approval.

About TransCanna Holdings Inc.

Keep reading... Show less

Donation will benefit veteran-focused organizations and nonprofits, including all TruVet Program partners

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a United States -based leading medical cannabis company, announced today a donation for all TruVet Program partners year-to-date in honor of Veterans Day. A total of $15,000 representing a portion of the November proceeds from the Company’s limited-edition Freedom Pre-Roll product, will be shared among program partners, which are veteran-focused organizations andor nonprofits.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannibas, Inc. (“Aurora” or the “Company”) (NYSE:ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.comacb

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less